BioWorld MedTech

Dec. 31, 2014

CytoSorbents seeks IDE for intra-operative use of CytoSorb treatment

A device designed to be installed into a heart-lung machine and used intra-operatively during complex cardiac surgery in an effort to reduce post-operative complications may soon be making its way through the U.S. regulatory process. Read More

Six leading research centers launch Cancer Core Europe

Alpinion Medical Systems rolls out South Korea's first HIFU

Kalorama identifies top trends that impacted med-tech in 2014

Abbott sheds light on early results for tender offer

Heart Sync electrode latest in slew of recalls related to Philips AEDs

Briefly Noted

Modernizing Medicine completes acquisition of Aesyntix Health

Keeping you up to date on recent events with Oncology

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...